RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 128 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790,947 | +31.9% | 34,494 | -5.2% | 0.00% | +100.0% |
| Q2 2023 | $599,758 | -64.2% | 36,371 | -61.2% | 0.00% | -75.0% |
| Q1 2023 | $1,674,213 | +170.1% | 93,846 | +340.9% | 0.00% | +300.0% |
| Q4 2022 | $619,761 | -83.7% | 21,283 | -88.1% | 0.00% | -94.1% |
| Q1 2021 | $3,802,000 | +567.0% | 178,757 | +833.1% | 0.02% | +466.7% |
| Q4 2020 | $570,000 | -6.7% | 19,158 | -32.0% | 0.00% | -25.0% |
| Q3 2020 | $611,000 | +166.8% | 28,192 | +174.9% | 0.00% | +100.0% |
| Q2 2020 | $229,000 | +358.0% | 10,257 | +346.3% | 0.00% | – |
| Q3 2019 | $50,000 | -93.8% | 2,298 | -92.2% | 0.00% | -100.0% |
| Q1 2019 | $806,000 | +1200.0% | 29,430 | +1180.7% | 0.00% | +300.0% |
| Q4 2018 | $62,000 | – | 2,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |